Sponsor Pipeline

Beijing Bio-Targeting Therapeutics Technology Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06763965 Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive… Recurrent High-grade Glioma Enrolling by Invitation
Phase 1
NCT06215846 A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With… Solid Tumor Enrolling by Invitation
NCT07472790 A Study on the Novel Oncolytic Virus Combined With PD-1 Inhibitor in the Treatment of… High-grade Glioma Not Yet Recruiting
Disease Areas
Glioma (2)
Get alerts when Beijing Bio-Targeting Therapeutics Technology Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free